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2019 (COVID-19) was first reported to the World Health Organization 
(WHO) on 31 December 2019 from Wuhan province of China as a cluster 
of pneumonia cases. The WHO on 11 March 2020 declared this as a global 
pandemic. COVID-19 is caused by SARS CoV 2 virus which is a member of the 
coronaviruses. 
South Sudan had 35 confirmed cases by 30 April with the first case announced 
on 4 April, 2020 while the last case (of the 35) declared on 29 April 2020.
WHO case definition - suspected COVID-19 case
• Any person with acute respiratory illness (fever and at least one sign/symptom 
of respiratory disease (e.g., cough, shortness of breath) 
AND 
• With no other aetiology that fully explains the clinical presentation 
AND 
• A history of travel to/or residence in a country / area or territory reporting 
local transmission of COVID-19 disease during the 14 days prior to 
symptom onset.[1] 
Clinical presentation
The majority of persons with COVID-19 exhibit no symptoms, however 
around 20% of patients will have fever, dry cough, fatigue, anorexia, shortness 
of breath, anosmia, productive cough and myalgia.[2] While gastroenterological 
and neurological symptoms were reported in less than 10% in certain studies.[3] 
Also, it is worth mentioning that a patient might present with either a combination 
of the above symptoms or any single one of them. 
Assessments and initial investigations in COVID-19 suspects
Clinical assessment
A COVID-19 patient should follow the same assessment as that of any 
respiratory case, ensuring that Personal Protective Equipment (PPE) is worn by 
the health staff. That is to say, the ABCDE approach is followed, addressing each 
abnormality as it is found. 
Suspected and positive COVID-19 cases should be isolated in designated areas 
which must be different from those areas where non COVID-19 patients are 
managed. Those patients deemed to be severely ill should be managed in a high 
dependency or intensive care unit. If a suspected case turns out to be negative, 
then consider an alternative diagnosis and manage accordingly.  False negatives 
exist in COVID-19 cases probably due to errors of sampling when specimens are 
collected by nasopharyngeal swabbing.
Haematology and biochemistry
Complete Blood Count usually shows a significantly low lymphocytes count with 
neutrophil to lymphocyte ratio of >1.3. This ratio is found to be useful as an 
independent mortality risk factor.[4] Leukocytosis and neutrophilia are predictors 
of superimposed bacterial infection. However, this should be correlated with a 
clinical judgment to ensure antimicrobial stewardship is observed. 
Elevated C-reactive protein (CRP), D-dimers and normal pro-calcitonin are 
common features of COVID-19 although not always.[5]
Baseline Urea and Electrolytes and Liver Function Tests (LFTs). There is no known 
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trend relating COVID-19 and abnormalities for these 
indices. However, it is important to know the baseline on 
admission. 
Microbiology
The diagnosis of COVID-19 is confirmed by isolating 
the SARS-CoV-2 virus from a nasopharyngeal or 
oropharyngeal swab by a RT-PCR. Deeper respiratory 
samples such as those obtained during bronchoalveolar 
lavage can equally be used for isolating SARS-CoV-2.
Check sputum for microscopy, culture and sensitivity 
Acid and Alcohol Fast Bacilli (AAFB).
Blood culture (not available in government hospitals in 
South Sudan at the moment) is quite important due to 
the fact that, COVID-19 victims may present with fever 
and cough but, bacterial septic patients could present in 
the same way. Therefore, ruling out a bacterial infection 
is of paramount importance. Clinical judgment becomes 
crucial in a setting with no blood culture facilities.
Radiology
Do a chest X-ray looking for bilateral lower lobes infiltrates 
and CT scan of the chest (if available) looking for bilateral 
ground glass changes. Note that no government hospital 
in South Sudan currently has a CT scan machine. 
Criteria for hospital admission
The main reason for admission of COVID-19 patients 
is respiratory compromise. Therefore, the WHO 
recommends the admission of the following groups of 
patients presenting with:
• Shortness of breath
• Low/reduced oxygen saturation for age and co-
morbidity
• Fever
• Respiratory failure of any type
Medical management of a COVID-19 suspect/patient
For positive cases, determine severity and admission 
criteria as mentioned above. Review observations which 
are oxygen saturation, respiratory rate, blood pressure, 
pulse rate and temperature. Each abnormality identified 
in the observations should be addressed.
Therefore, aim for SpO2 of 90-96% for majority of 
patients and adjust oxygen provision accordingly. Please 
note that the maximum quantity of oxygen that should 
be delivered via nasal cannulae is 4L/minute. Anything 
more than this via nasal cannulae is considered aerosol 
generating and therefore will require different types of 
PPEs.
Lying in the prone position has been proven to improve 
oxygenation significantly and therefore should be tried on 
patients who can tolerate it. 
Paracetamol and analgesia for fevers and myalgias
Intravenous fluid therapy should be given with caution. 
Over-hydration is associated with increased risk of 
intubation being required in COVID-19 patients.
Consider antimicrobials for super-added community 
acquired pneumonia (usually a penicillin +/- macrolide) if 
clinically, biochemically and radiologically indicated. Use 
the CURB65 severity score to assess severity of illness, 
C=confusion, U=Blood urea nitrogen >7mmol/litre, 
R-respiratory rate ≥30/minute, B=systolic blood pressure 
<90mmHg, or diastolic blood pressure ≤60mmHg, 
65=Age and above 65. Each positive on the CURB65 
scores one (1) point. The severity of the condition is 
BOX 1. CURB65 score for mortality 
risk assessment in hospitala 
CURB65 score is calculated by giving 1 point 
for each of the following prognostic features:
• confusion (abbreviated Mental Test 
score 8 or less, or new disorientation in 
person, place or time)b
• raised blood urea nitrogen (over 7 mmol/
litre)
• raised respiratory rate (30 breaths per 
minute or more)
• low blood pressure (diastolic 60 mmHg or 
less, or systolic less than 90 mmHg)
• age 65 years or more.
Patients are stratified for risk of death as 
follows:
• 0 or 1: low risk (less than 3% mortality 
risk)
• 2: intermediate risk (3 15% mortality 
risk)
• 3 to 5: high risk (more than 15% 
mortality risk).
Reference
a. Lim WS, van der Eerden MM, Laing R 
et al. Defining community acquired 
pneumonia severity on presentation 
to hospital: an international derivation 
and validation study. Thorax 2003;58: 
377–82.
b. For guidance on delirium, see the NICE 
guideline on delirium.
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assessed on the following scale: 1 is low risk, 2 is short 
inpatient stay or manage as an outpatient, 3 manage as 
an inpatient and consider Intensive Care Unit (ICU) 
admission, 4 or 5 intensive management with high 
probability of ICU treatment.
Consider enrolling patients on any COVID-19 trials 
whenever feasible.
Observe patients with COVID-19 for signs of clinical 
deterioration, such as progressive respiratory failure by 
monitoring the respiratory rate and arterial blood gases 
and sepsis by measuring the lactate dehydrogenase levels 
(LDH > 49-90 units per litre) and respond promptly with 
appropriate intervention.
Patients who failed to respond to standard oxygen therapy, 
should be provided with high oxygen flow and assessed for 
mechanical ventilator support. Their management should 
be escalated early to an ICU. The ICU management is 
outside the scope of this paper.
Discharge criteria
1. Symptoms resolution
2. Viral clearance as documented by two negative viral 
PCR in two nasopharangeal samples collected 24 
hours apart. A repeat swab should be done at least 
seven days from the start of symptoms and 48 hours 
of being fever free (though some guidelines say fever 
free without the use of an antipyrexic drugs).[6] 
However, note that point 2 above might not be practical 
especially when capacity is limited as in South Sudan. In 
such a case, patients can be discharged home even with 
positive results when they feel well. This will require close 
remote follow up by telephone. These patients should be 
advised to self-isolate for 14 days from symptom onset. 
It is worth mentioning that all the preventive measures 
should be explained to/and maintained by both swab 
positive and negative individuals.
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